Mitomycin C-induced organ toxicity in Wistar rats: a study with special focus on the kidney

J. Verweij, S. Kerpel-Fronius, M. Stuurman, A. J. van Triet, L. van Hattum, J. de Vries, H. M. Pinedo

Research output: Contribution to journalArticle

Abstract

Two studies were performed to investigate acute and chronic organ toxicity after Mitomycin C (MMC) administration in Wistar rats. Six rats received 2.5 mg/kg MMC i.p. once and were followed for 5 consecutive days. The alanine aminopeptidase (AAP)/creatinine ratio increased significantly, compared to a control group receiving saline. Four groups of rats were injected i.p. weekly for 5 weeks; 6 control rats with saline, 7 rats with 1.7 mg/kg of MMC, 7 rats with 10 mg/kg 5-fluorouracil (5-FU) and 7 rats with MMC as well as 5-FU. The latter two groups were included to study possible toxicity synergism between the two drugs. A significant decrease in AAP excretion in the MMC group, as well as a nonsignificant decrease in the MMC/5-FU group were the most remarkable observations. Light microscopy did not show renal changes, but did show alveolar septal congestion after repeated MMC injections. It is concluded that MMC causes tubular damage in Wistar rats, with acute leakage of enzyme from the cells, followed by enzyme depletion during chronic treatment. Also MMC induces pulmonary changes in Wistar rats. To what extent these changes represent early stages of toxicity remains to be elucidated.

Original languageEnglish (US)
Pages (from-to)137-141
Number of pages5
JournalJournal of Cancer Research and Clinical Oncology
Volume114
Issue number2
DOIs
StatePublished - Apr 1988
Externally publishedYes

Fingerprint

Mitomycin
Wistar Rats
Kidney
Fluorouracil
CD13 Antigens
Enzymes
Microscopy
Creatinine
Light
Lung
Control Groups
Injections

Keywords

  • AAP
  • HUS
  • Mitomycin C
  • NAG
  • Renal toxicity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Verweij, J., Kerpel-Fronius, S., Stuurman, M., van Triet, A. J., van Hattum, L., de Vries, J., & Pinedo, H. M. (1988). Mitomycin C-induced organ toxicity in Wistar rats: a study with special focus on the kidney. Journal of Cancer Research and Clinical Oncology, 114(2), 137-141. https://doi.org/10.1007/BF00417827

Mitomycin C-induced organ toxicity in Wistar rats : a study with special focus on the kidney. / Verweij, J.; Kerpel-Fronius, S.; Stuurman, M.; van Triet, A. J.; van Hattum, L.; de Vries, J.; Pinedo, H. M.

In: Journal of Cancer Research and Clinical Oncology, Vol. 114, No. 2, 04.1988, p. 137-141.

Research output: Contribution to journalArticle

Verweij, J, Kerpel-Fronius, S, Stuurman, M, van Triet, AJ, van Hattum, L, de Vries, J & Pinedo, HM 1988, 'Mitomycin C-induced organ toxicity in Wistar rats: a study with special focus on the kidney', Journal of Cancer Research and Clinical Oncology, vol. 114, no. 2, pp. 137-141. https://doi.org/10.1007/BF00417827
Verweij J, Kerpel-Fronius S, Stuurman M, van Triet AJ, van Hattum L, de Vries J et al. Mitomycin C-induced organ toxicity in Wistar rats: a study with special focus on the kidney. Journal of Cancer Research and Clinical Oncology. 1988 Apr;114(2):137-141. https://doi.org/10.1007/BF00417827
Verweij, J. ; Kerpel-Fronius, S. ; Stuurman, M. ; van Triet, A. J. ; van Hattum, L. ; de Vries, J. ; Pinedo, H. M. / Mitomycin C-induced organ toxicity in Wistar rats : a study with special focus on the kidney. In: Journal of Cancer Research and Clinical Oncology. 1988 ; Vol. 114, No. 2. pp. 137-141.
@article{46208f5523a9478abf27239d72f8fa7f,
title = "Mitomycin C-induced organ toxicity in Wistar rats: a study with special focus on the kidney",
abstract = "Two studies were performed to investigate acute and chronic organ toxicity after Mitomycin C (MMC) administration in Wistar rats. Six rats received 2.5 mg/kg MMC i.p. once and were followed for 5 consecutive days. The alanine aminopeptidase (AAP)/creatinine ratio increased significantly, compared to a control group receiving saline. Four groups of rats were injected i.p. weekly for 5 weeks; 6 control rats with saline, 7 rats with 1.7 mg/kg of MMC, 7 rats with 10 mg/kg 5-fluorouracil (5-FU) and 7 rats with MMC as well as 5-FU. The latter two groups were included to study possible toxicity synergism between the two drugs. A significant decrease in AAP excretion in the MMC group, as well as a nonsignificant decrease in the MMC/5-FU group were the most remarkable observations. Light microscopy did not show renal changes, but did show alveolar septal congestion after repeated MMC injections. It is concluded that MMC causes tubular damage in Wistar rats, with acute leakage of enzyme from the cells, followed by enzyme depletion during chronic treatment. Also MMC induces pulmonary changes in Wistar rats. To what extent these changes represent early stages of toxicity remains to be elucidated.",
keywords = "AAP, HUS, Mitomycin C, NAG, Renal toxicity",
author = "J. Verweij and S. Kerpel-Fronius and M. Stuurman and {van Triet}, {A. J.} and {van Hattum}, L. and {de Vries}, J. and Pinedo, {H. M.}",
year = "1988",
month = "4",
doi = "10.1007/BF00417827",
language = "English (US)",
volume = "114",
pages = "137--141",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Mitomycin C-induced organ toxicity in Wistar rats

T2 - a study with special focus on the kidney

AU - Verweij, J.

AU - Kerpel-Fronius, S.

AU - Stuurman, M.

AU - van Triet, A. J.

AU - van Hattum, L.

AU - de Vries, J.

AU - Pinedo, H. M.

PY - 1988/4

Y1 - 1988/4

N2 - Two studies were performed to investigate acute and chronic organ toxicity after Mitomycin C (MMC) administration in Wistar rats. Six rats received 2.5 mg/kg MMC i.p. once and were followed for 5 consecutive days. The alanine aminopeptidase (AAP)/creatinine ratio increased significantly, compared to a control group receiving saline. Four groups of rats were injected i.p. weekly for 5 weeks; 6 control rats with saline, 7 rats with 1.7 mg/kg of MMC, 7 rats with 10 mg/kg 5-fluorouracil (5-FU) and 7 rats with MMC as well as 5-FU. The latter two groups were included to study possible toxicity synergism between the two drugs. A significant decrease in AAP excretion in the MMC group, as well as a nonsignificant decrease in the MMC/5-FU group were the most remarkable observations. Light microscopy did not show renal changes, but did show alveolar septal congestion after repeated MMC injections. It is concluded that MMC causes tubular damage in Wistar rats, with acute leakage of enzyme from the cells, followed by enzyme depletion during chronic treatment. Also MMC induces pulmonary changes in Wistar rats. To what extent these changes represent early stages of toxicity remains to be elucidated.

AB - Two studies were performed to investigate acute and chronic organ toxicity after Mitomycin C (MMC) administration in Wistar rats. Six rats received 2.5 mg/kg MMC i.p. once and were followed for 5 consecutive days. The alanine aminopeptidase (AAP)/creatinine ratio increased significantly, compared to a control group receiving saline. Four groups of rats were injected i.p. weekly for 5 weeks; 6 control rats with saline, 7 rats with 1.7 mg/kg of MMC, 7 rats with 10 mg/kg 5-fluorouracil (5-FU) and 7 rats with MMC as well as 5-FU. The latter two groups were included to study possible toxicity synergism between the two drugs. A significant decrease in AAP excretion in the MMC group, as well as a nonsignificant decrease in the MMC/5-FU group were the most remarkable observations. Light microscopy did not show renal changes, but did show alveolar septal congestion after repeated MMC injections. It is concluded that MMC causes tubular damage in Wistar rats, with acute leakage of enzyme from the cells, followed by enzyme depletion during chronic treatment. Also MMC induces pulmonary changes in Wistar rats. To what extent these changes represent early stages of toxicity remains to be elucidated.

KW - AAP

KW - HUS

KW - Mitomycin C

KW - NAG

KW - Renal toxicity

UR - http://www.scopus.com/inward/record.url?scp=0023847870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023847870&partnerID=8YFLogxK

U2 - 10.1007/BF00417827

DO - 10.1007/BF00417827

M3 - Article

C2 - 3127399

AN - SCOPUS:0023847870

VL - 114

SP - 137

EP - 141

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 2

ER -